All News

2068 articles, sorted by publication time.

Biotechnology · global

Cellares Secures Regulatory and Supply Agreements as Automated Cell Therapy Manufacturing Reaches a Scaling Inflection Point

The next phase of competition in cell therapy is not only about targets and clinical responses, but also whether every batch of cells can be produced stably, on time, and in compliance. Cellares’ recent selection for an FDA pilot, commercial supply agreement, and onboarding of a new therapy bring automated manufacturing closer to industrial infrastructure rather than just an engineering promise.